<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-26643" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Parapneumonic Pleural Effusions and Empyema Thoracis</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Shebl</surname>
            <given-names>Eman</given-names>
          </name>
          <aff>Zagazig University Faculty of Medicine</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Paul</surname>
            <given-names>Manju</given-names>
          </name>
          <aff>SUNY Upstate Medical University</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Eman Shebl declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Manju Paul declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>7</day>
          <month>8</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-26643.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>A parapneumonic effusion refers to the accumulation of exudative pleural fluid associated with an ipsilateral lung infection, mainly pneumonia. Parapneumonic effusions are mainly associated with bacterial infections. This activity reviews the pathophysiology and presentation of parapneumonic effusions and highlights the role of the interprofessional team in its management.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the etiology of parapneumonic effusions.</p></list-item><list-item><p>Review the presentation of parapneumonic effusions.</p></list-item><list-item><p>Outline the treatment and management options available for parapneumonic effusions.</p></list-item><list-item><p>Describe interprofessional team strategies for improving care and outcomes in patients with parapneumonic effusions.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=26643&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=26643">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-26643.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>A parapneumonic effusion refers to the accumulation of exudative pleural fluid associated with an ipsilateral lung infection, mainly pneumonia. Parapneumonic effusions are mainly associated with bacterial infections.<xref ref-type="bibr" rid="article-26643.r1">[1]</xref></p>
        <p>Parapneumonic pleural effusions are classified into:</p>
        <list list-type="bullet">
          <list-item>
            <p>Uncomplicated parapneumonic effusions, which are exudative, &#x000a0;neutrophilic effusion.&#x000a0;Gram stain and culture are negative, glucose level greater than 60 mg/dl, pH above 7.20.</p>
          </list-item>
          <list-item>
            <p>Complicated parapneumonic effusions, resulting from a bacterial introduction into the pleura. In this type of&#x000a0;parapneumonic effusion, there is a&#x000a0;decreased glucose level, pleural fluid is below 7.20.&#x000a0;Cultures of fluid from complicated parapneumonic effusions are negative and rapid bacterial clearance from the pleural space, or low bacterial count may explain this. The fluid termed as complicated because it necessitates drainage for resolution.</p>
          </list-item>
          <list-item>
            <p>Empyema thoracis in which there is frank pus in the pleural space, or there is evidence of bacterial infection of the pleural fluid by Gram stain or a positive culture.<xref ref-type="bibr" rid="article-26643.r2">[2]</xref><xref ref-type="bibr" rid="article-26643.r3">[3]</xref></p>
          </list-item>
        </list>
        <p>Pleural effusions are common in patients who develop pneumonia. At least 40-60% of patients with bacterial pneumonia will develop a pleural effusion of varying severity. Today, these parapneumonic effusions are not common because of prompt antibiotic therapy. However, in some patients the parapneumonic effusion becomes fibrinous and later develops an infection, resulting in an empyema.</p>
      </sec>
      <sec id="article-26643.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Pneumonia is the most frequent cause of parapneumonic effusions and empyema thoracis. Empyema may result as a complication of cardiothoracic surgery. Trauma can also lead to infection of the pleural space. The infecting organism may have spread from blood or other organs into the pleural space.<xref ref-type="bibr" rid="article-26643.r4">[4]</xref><xref ref-type="bibr" rid="article-26643.r5">[5]</xref></p>
        <p>Both viruses and bacteria can cause parapneumonic effusions, but it is the latter that is the most common cause of empyema thoracis.</p>
        <p>
<bold>Risk Factors</bold>
</p>
        <p>There are risk factors for empyema like age and comorbidities such as diabetes, alcoholism, GERD, advanced age and repeated hospitalization for pneumonia.<xref ref-type="bibr" rid="article-26643.r4">[4]</xref></p>
        <p>
<bold>Bacteriology</bold>
</p>
        <p><italic toggle="yes">Streptococcus</italic><italic toggle="yes"><italic toggle="yes">&#x000a0;</italic>pneumoniae</italic>&#x000a0;and&#x000a0;<italic toggle="yes">Staphylococcus aureus&#x000a0;</italic>are&#x000a0;responsible for about 70% of aerobic gram-positive cultures.<italic toggle="yes"> Klebsiella, Pseudomonas,</italic>&#x000a0;and&#x000a0;<italic toggle="yes">Haemophilus</italic>&#x000a0;species are the commonest in gram-negative culture.&#x000a0;<italic toggle="yes">Bacteroides</italic>&#x000a0;and&#x000a0;<italic toggle="yes">Peptostreptococcus&#x000a0;</italic>species are the commonest anaerobic organisms. In empyema thoracis associated with aspiration pneumonia mixed bacterial florae containing aerobic and anaerobic bacteria are common.&#x000a0;The common organism in cases of empyema thoracis complicating surgery is&#x000a0;<italic toggle="yes">S. aureus.</italic><xref ref-type="bibr" rid="article-26643.r4">[4]</xref><xref ref-type="bibr" rid="article-26643.r6">[6]</xref></p>
        <p>A very common cause of infection of the chest cavity is trauma. Any hemothorax that is not adequately evacuated can result in an empyema. Other causes include mediastinitis, ruptured esophagus, pericarditis, pancreatitis, and subdiaphragmatic abscesses.</p>
      </sec>
      <sec id="article-26643.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Parapneumonic effusion develops in about 20% to 40% of patients hospitalized with pneumonia. Approximately 1 million patients develop parapneumonic effusion annually in the United States.<xref ref-type="bibr" rid="article-26643.r2">[2]</xref><xref ref-type="bibr" rid="article-26643.r7">[7]</xref></p>
        <p>Despite a large number of parapneumonic effusions following pneumonia, less than 10% require aspiration.</p>
      </sec>
      <sec id="article-26643.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>&#x000a0;The stages of&#x000a0;parapneumonic effusion are:</p>
        <list list-type="order">
          <list-item>
            <p><italic toggle="yes">Exudative stage,</italic> in which there is an accumulation of fluid in the pleural space due to increased capillary permeability that results from proinflammatory cytokines, such as interleukin 8 (IL-8) and tumor necrosis factor-alpha (TNF-a). The pleural fluid in this early stage is usually clear exudative fluid with a predominance of neutrophils. Pleural fluid in this stage is simple parapneumonic effusion that usually resolves with adequate antibiotic treatment of pneumonia without the need for drainage. This stage takes approximately 2 to 5 days from the onset of pneumonia.</p>
          </list-item>
          <list-item>
            <p><italic toggle="yes">Fibrinopurulent stage,</italic> which can develop if adequate treatment is not provided. In this stage there is a deposition of fibrin clots and fibrin membranes in the pleural cavity, leading to fluid loculations. This stage takes about 5 to 10 days after pneumonia onset.</p>
          </list-item>
          <list-item>
            <p><italic toggle="yes">Organizing stage,</italic> in which fibrin membranes are transformed by fibroblast into a thick nonelastic pleural peel, resulting in the trapped lung with restrictive respiratory dysfunction. This stage may take about 2 to 3 weeks to develop.</p>
          </list-item>
        </list>
        <p>The clinical course varies from spontaneous healing to chronic empyema and fibro-thorax with trapped&#x000a0;restricted lung.<xref ref-type="bibr" rid="article-26643.r8">[8]</xref></p>
      </sec>
      <sec id="article-26643.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>The clinical manifestations of parapneumonic effusion or empyema are related to various factors like the presentation timing and the virulence of the causative organism. Common symptoms of bacterial pneumonia with parapneumonic effusion include a cough, expectoration, and a rise in body temperature, pleuritic chest pain, and difficulty breathing.</p>
        <p>In most patients the following clinical signs are present in clinical examination and include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Fever, tachypnea, and tachycardia</p>
          </list-item>
          <list-item>
            <p>Pleural effusion (dullness to percussion decreased tactile fremitus and decreased or absent breath sounds)</p>
          </list-item>
          <list-item>
            <p>Adjacent pneumonia (rales or crackles and/or bronchial breath sounds)<xref ref-type="bibr" rid="article-26643.r9">[9]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-26643.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>
<bold>Radiographic Investigations</bold>
</p>
        <p>Plain chest x-ray: Pleural&#x000a0;effusion&#x000a0;can easily be detected by conventional radiographic. The consistency of these pleural-based densities suggests pleural fluid loculation.<xref ref-type="bibr" rid="article-26643.r1">[1]</xref></p>
        <p><italic toggle="yes">Chest ultrasound:</italic>&#x000a0;Ultrasonography helps identify free or loculated pleural effusions and helps with thoracentesis guidance.<xref ref-type="bibr" rid="article-26643.r10">[10]</xref></p>
        <p><italic toggle="yes">Chest computed tomography (CT):</italic>&#x000a0;For empyema or loculated effusion in adults, a CT scan with intravenous contrast is helpful. Radiographic contrast enhances the visualization of the pleural surfaces and helps identify pleural fluid loculations. Empyema is suggested by the presence of a split pleura sign in which there is a thickening of the visceral and parietal pleura with significant separation of the pleural surfaces. CT helps in detecting underlying parenchymal abnormalities.<xref ref-type="bibr" rid="article-26643.r11">[11]</xref></p>
        <p>
<bold>Thoracentesis</bold>
</p>
        <p>A diagnostic thoracentesis is needed for the management guidance of parapneumonic pleural effusion. In general, a parapneumonic effusion should be sampled if It is a free-flowing and layers greater than 10-mm on a lateral decubitus film. Radiological guidance of thoracentesis by ultrasound or chest computed tomography (CT) in some cases is helpful especially when the effusion is loculated.<xref ref-type="bibr" rid="article-26643.r12">[12]</xref>&#x000a0;The aspirated pleural fluid&#x000a0;is&#x000a0;subjected to:</p>
        <list list-type="bullet">
          <list-item>
            <p><italic toggle="yes">Microbiologic analysis:</italic> Gram stain with cultures and sensitivity (aerobic and anaerobic)</p>
          </list-item>
          <list-item>
            <p>
<italic toggle="yes">Pleural fluid total and differential cell count</italic>
</p>
          </list-item>
          <list-item>
            <p><italic toggle="yes">Biochemical analysis:</italic> Total protein, lactate dehydrogenase, glucose) and&#x000a0; pH</p>
          </list-item>
          <list-item>
            <p><italic toggle="yes">Pleural fluid biomarkers:</italic> Novel biomarkers of infection (e.g., C-reactive protein, procalcitonin, STREM-1) have been&#x000a0;evaluated to help distinguish complicated parapneumonic pleural effusions from uncomplicated parapneumonic pleural effusions, but there is no proven superiority to traditional pleural biochemistries.<xref ref-type="bibr" rid="article-26643.r13">[13]</xref><xref ref-type="bibr" rid="article-26643.r14">[14]</xref></p>
          </list-item>
        </list>
        <p>More appropriate investigations&#x000a0;should be performed to exclude other causes of pleural effusion when indicated.</p>
      </sec>
      <sec id="article-26643.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Treatment of parapneumonic effusion includes appropriate antibiotic therapy together with drainage of pleural fluid as indicated.&#x000a0;</p>
        <p>Parapneumonic effusion is classified into 4 groups based on risk for the poor outcome:</p>
        <list list-type="bullet">
          <list-item>
            <p><italic toggle="yes">Category 1 (very&#x000a0;low risk): </italic>The effusion is small (less than 10-mm thickness on decubitus) and free-flowing. No thoracentesis is indicated.</p>
          </list-item>
          <list-item>
            <p><italic toggle="yes">Category 2 (low risk): </italic>The effusion is small to moderate (equal to 10 mm and less than half the hemithorax) and free-flowing with negative culture and Gram stain regardless of the prior use of antibiotics and pH equal to 7.20.</p>
          </list-item>
          <list-item>
            <p><italic toggle="yes">Category 3 (moderate risk), in which one of the following criteria is present:</italic> &#x000a0;the fluid equal to&#x000a0;half the hemithorax, loculated effusion, thicken pleura on contrast-enhanced CT scan, positive Gram stain or culture or pH less than 7.20.</p>
          </list-item>
          <list-item>
            <p><italic toggle="yes">Category 4 (high risk):</italic> This is when pleural fluid is in the form of pure pus.</p>
          </list-item>
        </list>
        <p>Patients with category 1 and category 2 may not require drainage. In patients with category 3 and 4,&#x000a0;drainage&#x000a0;is&#x000a0;recommended. Fibrinolytics, VATS, and surgery may be indicated for managing patients with category 3 and category 4 parapneumonic effusion not responding to less invasive drainage methods.<xref ref-type="bibr" rid="article-26643.r12">[12]</xref></p>
        <p>
<bold>Antibiotic Therapy </bold>
</p>
        <p>It must cover the suggested&#x000a0;causative organisms of pneumonia according to the clinical setting. The duration of antibiotic therapy depends on many factors, for example, the sensitivity of the organism, extent of pulmonary parenchymal and pleural disease, response to initial therapy and adequacy of drainage.<xref ref-type="bibr" rid="article-26643.r15">[15]</xref></p>
        <p>
<bold>Chest Tube Drainage</bold>
</p>
        <p>Chest tube drainage is generally preferred for patients with uninoculated effusions and free-flowing fluid. Chest tubes are ideally inserted under ultrasound or CT-guidance. The choice of a thoracostomy tube size is controversial. Imaging performed within 24 hours is essential for documenting the correct position of the chest tube. Chest tubes are left in place until the drainage rate is less than 50&#x000a0;ml per day&#x000a0;and the empyema cavity has closed.<xref ref-type="bibr" rid="article-26643.r15">[15]</xref></p>
        <p><bold>Fibrinolytic Agents</bold>&#x000a0;</p>
        <p>The intrapleural administration for fibrinolytic agents (for example, streptokinase and tissue plasminogen activator) or fibrinolytic plus mucolytic agents&#x000a0;aiming for facilitating the drainage of the loculated parapneumonic effusion is controversial.<xref ref-type="bibr" rid="article-26643.r16">[16]</xref><xref ref-type="bibr" rid="article-26643.r17">[17]</xref></p>
        <p>
<bold>Thoracoscopy</bold>
</p>
        <p>Thoracoscopy is an alternative therapy for loculated empyemas when antibiotics and tube thoracostomy fail for the drainage. Thoracoscopy disrupts the intrapleural adhesions and allows the drainage of the pleural fluid.<xref ref-type="bibr" rid="article-26643.r18">[18]</xref>&#x000a0;Previous studies showed that delay for referral for thoracoscopy more than two weeks was associated with failure of thoracoscopy and conversion to thoracotomy.<xref ref-type="bibr" rid="article-26643.r19">[19]</xref></p>
        <p><bold>Decortication</bold>&#x000a0;</p>
        <p>Decortication&#x000a0;is indicated when persistent (present after 6 months) pleural peel is formed, leading to significant pulmonary restriction.<xref ref-type="bibr" rid="article-26643.r20">[20]</xref></p>
        <p>
<bold>Rib Resection and Open Drainage of Pleural Space</bold>
</p>
        <p>A vertical incision through the chest wall with rib resection (1 to 3) is done to allow pleural fluid drainage. A chest tube&#x000a0;is left in place (about 60 to 90 days). Open&#x000a0;drainage of the pleural space may be considered when the previous methods fail, and when the patient is too ill to tolerate decortications.<xref ref-type="bibr" rid="article-26643.r20">[20]</xref></p>
      </sec>
      <sec id="article-26643.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <list list-type="bullet">
          <list-item>
            <p>Bacterial pneumonia</p>
          </list-item>
          <list-item>
            <p>Perforated esophagus</p>
          </list-item>
          <list-item>
            <p>Hemothorax</p>
          </list-item>
          <list-item>
            <p>Chylothorax</p>
          </list-item>
          <list-item>
            <p>Lung cancer</p>
          </list-item>
          <list-item>
            <p>Tuberculosis</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-26643.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Most of the patients with parapneumonic pleural effusion recover, but the mortality rate still around 10%. Proper antibiotic therapy and pleural fluid drainage are vital for recovery.<xref ref-type="bibr" rid="article-26643.r1">[1]</xref>&#x000a0;Scoring&#x000a0;systems&#x000a0;have been studied (RAPID score) to determine which patients with parapneumonic effusions are at the highest risk for a poor outcome.<xref ref-type="bibr" rid="article-26643.r21">[21]</xref></p>
        <p>Other factors that complicate treatment include patient age, cardiac and respiratory compromise, immunosuppression, and frailty. Overall, death rates are higher in older patients.</p>
      </sec>
      <sec id="article-26643.s11" sec-type="Complications">
        <title>Complications</title>
        <p>Complications of pleural empyema may include residual pleural thickening, extensive pleural fibrosis,&#x000a0;bronchopleural fistula formation, and development of empyema necessitans.<xref ref-type="bibr" rid="article-26643.r22">[22]</xref></p>
        <p>The surgery is also associated with numerous complications including pain, recurrence, prolonged hospital stay, injury to the chest organs, diaphragmatic paralysis and fractured ribs.</p>
      </sec>
      <sec id="article-26643.s12" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>Early diagnosis, appropriate antimicrobial therapy, and adequate drainage of parapneumonic effusion are essential for decreasing its morbidity and mortality.</p>
      </sec>
      <sec id="article-26643.s13" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>The&#x000a0;parapneumonic pleural effusion management requires interprofessional cooperation between physicians of the concerned specialties (e.g., pulmonary medicine, radiology, and microbiology and cardiothoracic surgery) for a good outcome. The interprofessional care provided to the patient must follow an evidence-based approach. [Level 3]</p>
      </sec>
      <sec id="article-26643.s14">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=26643&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=26643">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/lung-disease-respiratory-health/parapneumonic-pleural-effusions-and-empyema-thoracis/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=26643">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/26643/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=26643">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-26643.s15">
        <fig id="article-26643.image.f1" position="float" orientation="portrait">
          <caption>
            <p>CT Chest Bilateral Plueral Effusions Contributed by Scott Dulebohn, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="bilateral__pleural__effusions" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-26643.s16">
        <fig id="article-26643.image.f2" position="float" orientation="portrait">
          <caption>
            <p>Right Lung Pleural Effusion Radiograph, Posteroanterior. This upright posteroanterior chest x-ray&#x000a0;reveals a pleural effusion of the right lung. Contributed by S Bhimji, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="right__pleural__effusion" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-26643.s17">
        <fig id="article-26643.image.f3" position="float" orientation="portrait">
          <caption>
            <p>CT scan of chest effusions Image courtesy S Bhimji MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="CXR14" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-26643.s18">
        <fig id="article-26643.image.f4" position="float" orientation="portrait">
          <caption>
            <p>Consolidation and Plueral Effusion Contributed by Pranav Modi</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="consolidation__and__plural__effusion" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-26643.s19">
        <fig id="article-26643.image.f5" position="float" orientation="portrait">
          <caption>
            <p>Empyema chronic Image courtesy Dr Chaigasame</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="empyema1" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-26643.s20">
        <title>References</title>
        <ref id="article-26643.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Light</surname>
                <given-names>RW</given-names>
              </name>
              <name>
                <surname>Girard</surname>
                <given-names>WM</given-names>
              </name>
              <name>
                <surname>Jenkinson</surname>
                <given-names>SG</given-names>
              </name>
              <name>
                <surname>George</surname>
                <given-names>RB</given-names>
              </name>
            </person-group>
            <article-title>Parapneumonic effusions.</article-title>
            <source>Am J Med</source>
            <year>1980</year>
            <month>Oct</month>
            <volume>69</volume>
            <issue>4</issue>
            <fpage>507</fpage>
            <page-range>507-12</page-range>
            <pub-id pub-id-type="pmid">7424940</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26643.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Light</surname>
                <given-names>RW</given-names>
              </name>
            </person-group>
            <article-title>Parapneumonic effusions and empyema.</article-title>
            <source>Proc Am Thorac Soc</source>
            <year>2006</year>
            <volume>3</volume>
            <issue>1</issue>
            <fpage>75</fpage>
            <page-range>75-80</page-range>
            <pub-id pub-id-type="pmid">16493154</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26643.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Aquino</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Webb</surname>
                <given-names>WR</given-names>
              </name>
              <name>
                <surname>Gushiken</surname>
                <given-names>BJ</given-names>
              </name>
            </person-group>
            <article-title>Pleural exudates and transudates: diagnosis with contrast-enhanced CT.</article-title>
            <source>Radiology</source>
            <year>1994</year>
            <month>Sep</month>
            <volume>192</volume>
            <issue>3</issue>
            <fpage>803</fpage>
            <page-range>803-8</page-range>
            <pub-id pub-id-type="pmid">8058951</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26643.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tsang</surname>
                <given-names>KY</given-names>
              </name>
              <name>
                <surname>Leung</surname>
                <given-names>WS</given-names>
              </name>
              <name>
                <surname>Chan</surname>
                <given-names>VL</given-names>
              </name>
              <name>
                <surname>Lin</surname>
                <given-names>AW</given-names>
              </name>
              <name>
                <surname>Chu</surname>
                <given-names>CM</given-names>
              </name>
            </person-group>
            <article-title>Complicated parapneumonic effusion and empyema thoracis: microbiology and predictors of adverse outcomes.</article-title>
            <source>Hong Kong Med J</source>
            <year>2007</year>
            <month>Jun</month>
            <volume>13</volume>
            <issue>3</issue>
            <fpage>178</fpage>
            <page-range>178-86</page-range>
            <pub-id pub-id-type="pmid">17548905</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26643.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bartlett</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>Gorbach</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Thadepalli</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Finegold</surname>
                <given-names>SM</given-names>
              </name>
            </person-group>
            <article-title>Bacteriology of empyema.</article-title>
            <source>Lancet</source>
            <year>1974</year>
            <month>Mar</month>
            <day>02</day>
            <volume>1</volume>
            <issue>7853</issue>
            <fpage>338</fpage>
            <page-range>338-40</page-range>
            <pub-id pub-id-type="pmid">4131173</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26643.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jerng</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Hsueh</surname>
                <given-names>PR</given-names>
              </name>
              <name>
                <surname>Teng</surname>
                <given-names>LJ</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>LN</given-names>
              </name>
              <name>
                <surname>Yang</surname>
                <given-names>PC</given-names>
              </name>
              <name>
                <surname>Luh</surname>
                <given-names>KT</given-names>
              </name>
            </person-group>
            <article-title>Empyema thoracis and lung abscess caused by viridans streptococci.</article-title>
            <source>Am J Respir Crit Care Med</source>
            <year>1997</year>
            <month>Nov</month>
            <volume>156</volume>
            <issue>5</issue>
            <fpage>1508</fpage>
            <page-range>1508-14</page-range>
            <pub-id pub-id-type="pmid">9372668</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26643.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Grijalva</surname>
                <given-names>CG</given-names>
              </name>
              <name>
                <surname>Zhu</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Nuorti</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Griffin</surname>
                <given-names>MR</given-names>
              </name>
            </person-group>
            <article-title>Emergence of parapneumonic empyema in the USA.</article-title>
            <source>Thorax</source>
            <year>2011</year>
            <month>Aug</month>
            <volume>66</volume>
            <issue>8</issue>
            <fpage>663</fpage>
            <page-range>663-8</page-range>
            <pub-id pub-id-type="pmid">21617169</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26643.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>McCauley</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Dean</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Pneumonia and empyema: causal, casual or unknown.</article-title>
            <source>J Thorac Dis</source>
            <year>2015</year>
            <month>Jun</month>
            <volume>7</volume>
            <issue>6</issue>
            <fpage>992</fpage>
            <page-range>992-8</page-range>
            <pub-id pub-id-type="pmid">26150912</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26643.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dean</surname>
                <given-names>NC</given-names>
              </name>
              <name>
                <surname>Griffith</surname>
                <given-names>PP</given-names>
              </name>
              <name>
                <surname>Sorensen</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>McCauley</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Jones</surname>
                <given-names>BE</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>YC</given-names>
              </name>
            </person-group>
            <article-title>Pleural Effusions at First ED Encounter Predict Worse Clinical Outcomes in Patients&#x000a0;With Pneumonia.</article-title>
            <source>Chest</source>
            <year>2016</year>
            <month>Jun</month>
            <volume>149</volume>
            <issue>6</issue>
            <fpage>1509</fpage>
            <page-range>1509-15</page-range>
            <pub-id pub-id-type="pmid">26836918</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26643.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Svigals</surname>
                <given-names>PZ</given-names>
              </name>
              <name>
                <surname>Chopra</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ravenel</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>Nietert</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Huggins</surname>
                <given-names>JT</given-names>
              </name>
            </person-group>
            <article-title>The accuracy of pleural ultrasonography in diagnosing complicated parapneumonic pleural effusions.</article-title>
            <source>Thorax</source>
            <year>2017</year>
            <month>Jan</month>
            <volume>72</volume>
            <issue>1</issue>
            <fpage>94</fpage>
            <page-range>94-95</page-range>
            <pub-id pub-id-type="pmid">27613540</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26643.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Waite</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Carbonneau</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Balikian</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Umali</surname>
                <given-names>CB</given-names>
              </name>
              <name>
                <surname>Pezzella</surname>
                <given-names>AT</given-names>
              </name>
              <name>
                <surname>Nash</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Parietal pleural changes in empyema: appearances at CT.</article-title>
            <source>Radiology</source>
            <year>1990</year>
            <month>Apr</month>
            <volume>175</volume>
            <issue>1</issue>
            <fpage>145</fpage>
            <page-range>145-50</page-range>
            <pub-id pub-id-type="pmid">2315473</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26643.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Colice</surname>
                <given-names>GL</given-names>
              </name>
              <name>
                <surname>Curtis</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Deslauriers</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Heffner</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Light</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Littenberg</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Sahn</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Weinstein</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Yusen</surname>
                <given-names>RD</given-names>
              </name>
            </person-group>
            <article-title>Medical and surgical treatment of parapneumonic effusions : an evidence-based guideline.</article-title>
            <source>Chest</source>
            <year>2000</year>
            <month>Oct</month>
            <volume>118</volume>
            <issue>4</issue>
            <fpage>1158</fpage>
            <page-range>1158-71</page-range>
            <pub-id pub-id-type="pmid">11035692</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26643.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chung</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>Hsiao</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Hsiao</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Sheu</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>WL</given-names>
              </name>
              <name>
                <surname>Chang</surname>
                <given-names>SC</given-names>
              </name>
            </person-group>
            <article-title>Clinical importance of angiogenic cytokines, fibrinolytic activity and effusion size in parapneumonic effusions.</article-title>
            <source>PLoS One</source>
            <year>2013</year>
            <volume>8</volume>
            <issue>1</issue>
            <fpage>e53169</fpage>
            <pub-id pub-id-type="pmid">23308155</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26643.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Porcel</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Bielsa</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Esquerda</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ruiz-Gonz&#x000e1;lez</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Falguera</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Pleural fluid C-reactive protein contributes to the diagnosis and assessment of severity of parapneumonic effusions.</article-title>
            <source>Eur J Intern Med</source>
            <year>2012</year>
            <month>Jul</month>
            <volume>23</volume>
            <issue>5</issue>
            <fpage>447</fpage>
            <page-range>447-50</page-range>
            <pub-id pub-id-type="pmid">22726374</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26643.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lee</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Oh</surname>
                <given-names>JY</given-names>
              </name>
              <name>
                <surname>Kang</surname>
                <given-names>CI</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>ES</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Rhee</surname>
                <given-names>CK</given-names>
              </name>
              <name>
                <surname>Jung</surname>
                <given-names>JY</given-names>
              </name>
              <name>
                <surname>Jo</surname>
                <given-names>KW</given-names>
              </name>
              <name>
                <surname>Heo</surname>
                <given-names>EY</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Suh</surname>
                <given-names>GY</given-names>
              </name>
              <name>
                <surname>Kiem</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Guideline for Antibiotic Use in Adults with Community-acquired Pneumonia.</article-title>
            <source>Infect Chemother</source>
            <year>2018</year>
            <month>Jun</month>
            <volume>50</volume>
            <issue>2</issue>
            <fpage>160</fpage>
            <page-range>160-198</page-range>
            <pub-id pub-id-type="pmid">29968985</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26643.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jerjes-S&#x000e1;nchez</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Ramirez-Rivera</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Elizalde</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Delgado</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Cicero</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Ibarra-Perez</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Arroliga</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Padua</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Portales</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Villarreal</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Perez-Romo</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Intrapleural fibrinolysis with streptokinase as an adjunctive treatment in hemothorax and empyema: a multicenter trial.</article-title>
            <source>Chest</source>
            <year>1996</year>
            <month>Jun</month>
            <volume>109</volume>
            <issue>6</issue>
            <fpage>1514</fpage>
            <page-range>1514-9</page-range>
            <pub-id pub-id-type="pmid">8769503</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26643.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gilbert</surname>
                <given-names>CR</given-names>
              </name>
              <name>
                <surname>Gorden</surname>
                <given-names>JA</given-names>
              </name>
            </person-group>
            <article-title>Use of intrapleural tissue plasminogen activator and deoxyribonuclease in pleural space infections: an update on alternative regimens.</article-title>
            <source>Curr Opin Pulm Med</source>
            <year>2017</year>
            <month>Jul</month>
            <volume>23</volume>
            <issue>4</issue>
            <fpage>371</fpage>
            <page-range>371-375</page-range>
            <pub-id pub-id-type="pmid">28399008</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26643.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cassina</surname>
                <given-names>PC</given-names>
              </name>
              <name>
                <surname>Hauser</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hillejan</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Greschuchna</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Stamatis</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Video-assisted thoracoscopy in the treatment of pleural empyema: stage-based management and outcome.</article-title>
            <source>J Thorac Cardiovasc Surg</source>
            <year>1999</year>
            <month>Feb</month>
            <volume>117</volume>
            <issue>2</issue>
            <fpage>234</fpage>
            <page-range>234-8</page-range>
            <pub-id pub-id-type="pmid">9918962</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26643.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pan</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>He</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Shen</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Jiang</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Liang</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>He</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>A meta-analysis of video-assisted thoracoscopic decortication versus open thoracotomy decortication for patients with empyema.</article-title>
            <source>J Thorac Dis</source>
            <year>2017</year>
            <month>Jul</month>
            <volume>9</volume>
            <issue>7</issue>
            <fpage>2006</fpage>
            <page-range>2006-2014</page-range>
            <pub-id pub-id-type="pmid">28840000</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26643.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ng</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Wan</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>TW</given-names>
              </name>
              <name>
                <surname>Wan</surname>
                <given-names>IY</given-names>
              </name>
              <name>
                <surname>Arifi</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Yim</surname>
                <given-names>AP</given-names>
              </name>
            </person-group>
            <article-title>Post-pneumonectomy empyema: current management strategies.</article-title>
            <source>ANZ J Surg</source>
            <year>2005</year>
            <month>Jul</month>
            <volume>75</volume>
            <issue>7</issue>
            <fpage>597</fpage>
            <page-range>597-602</page-range>
            <pub-id pub-id-type="pmid">15972055</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26643.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rahman</surname>
                <given-names>NM</given-names>
              </name>
              <name>
                <surname>Kahan</surname>
                <given-names>BC</given-names>
              </name>
              <name>
                <surname>Miller</surname>
                <given-names>RF</given-names>
              </name>
              <name>
                <surname>Gleeson</surname>
                <given-names>FV</given-names>
              </name>
              <name>
                <surname>Nunn</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Maskell</surname>
                <given-names>NA</given-names>
              </name>
            </person-group>
            <article-title>A clinical score (RAPID) to identify those at risk for poor outcome at presentation in patients with pleural infection.</article-title>
            <source>Chest</source>
            <year>2014</year>
            <month>Apr</month>
            <volume>145</volume>
            <issue>4</issue>
            <fpage>848</fpage>
            <page-range>848-855</page-range>
            <pub-id pub-id-type="pmid">24264558</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26643.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mart&#x000ed;nez</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Cordero</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Cases</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Sanchis</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Sanchis</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Ferrando</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Perpi&#x000f1;&#x000e1;</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>[Prognostic features of residual pleural thickening in metapneumonic pleural effusion].</article-title>
            <source>Arch Bronconeumol</source>
            <year>1999</year>
            <month>Mar</month>
            <volume>35</volume>
            <issue>3</issue>
            <fpage>108</fpage>
            <page-range>108-12</page-range>
            <pub-id pub-id-type="pmid">10216741</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
